Koji Habe

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Youn H. Kim, M. Bagot, Lauren Pinter‐Brown et al. · The Lancet Oncology · 2018 · 621 citations · Full text

Cutaneous T-cell Lymphoma, Lymphoid Neoplasia, Medicine +6

Human Mast Cell Chymase Cleaves Pro-IL-18 and Generates a Novel and Biologically Active IL-18 Fragment

Youichi Omoto, Kazuya Tokime, Keiichi Yamanaka et al. · The Journal of Immunology · 2006 · 134 citations · Full text

A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid

Masayuki Amagai, Shigaku Ikeda, Takashi Hashimoto et al. · Journal of Dermatological Science · 2016 · 93 citations

Vaccination, Veterinary Vaccine, Autoimmune Disease +6

Plasma ADAMTS13, von Willebrand Factor (VWF) and VWF Propeptide Profiles in Patients with DIC and Related Diseases

Koji Habe, Hideo Wada, Naomi Ito-Habe et al. · Thrombosis Research · 2011 · 69 citations

Inflammation, Autoimmune Disease, Vwf Propeptide Profiles +11

Alopecia Diffusa while Using Interleukin-17 Inhibitors against Psoriasis Vulgaris

Makiko Yajima, Tomoko Akeda, Makoto Kondo et al. · Case Reports in Dermatology · 2019 · 30 citations · Full text

Inflammation, Autoimmune Disease, Alopecia Diffusa +13